PRJIX (PRJIX) Stock Price & Analysis
PRJIX (PRJIX) fell 1.04% to USD 57.97 as of July 25, 2026 at 21:50 UTC, according to Nexqual real-time market data.
PRJIX last closed at USD 58.58; the session ranged USD 57.97–57.97 on volume of 0 shares. Market capitalization is —, with a 52-week range of USD 49.44–62.28 (NAS). Source: Nexqual, July 25, 2026 at 21:50 UTC.
Key Statistics (as of July 25, 2026 at 21:50 UTC)
| Price | USD 57.97 |
|---|---|
| Change | ▼ 1.04% (down) |
| Previous Close | USD 58.58 |
| Open | USD 57.97 |
| Day Range | USD 57.97 – 57.97 |
| 52-Week Range | USD 49.44 – 62.28 |
| Volume | 0 shares |
| Market Cap | — |
| Exchange | NAS |
Technical Analysis (PRJIX)
Nexqual's technical model rates PRJIX "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 21:50 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 45.19 (neutral) |
| vs SMA50 | Below (USD 59.26) |
| MACD | -0.31 (negative) |
Financial Health Score (PRJIX)
Nexqual rates PRJIX's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 21:50 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| THISX | T. Rowe Price Health Sciences F | USD 90.58 | ▲ 1.27% |
| RPTIX | T. Rowe Price Mid-Cap Growth Fu | USD 98.95 | ▼ 0.52% |
| PRUFX | T. Rowe Price Growth Stock Fund | USD 107.06 | ▼ 2.46% |
| TRAIX | T. Rowe Price Capital Appreciat | USD 37.77 | ▼ 0.74% |
| TTMIX | T. Rowe Price Communications & | USD 124.63 | ▼ 3.27% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 21:50 UTC. This page is informational and not investment advice.